Some of the key facts of the Clostridium Difficile Infections Market Report: ...

Immuron (IMRN) announced that it has submitted an Investigational New Drug, or IND, application to the FDA for clinical development of IMM-529.

Each year, 10 million episodes are treated with antibiotics, but half of the time subsequent urine testing fails to confirm ...

One by one, Mary Rutan Hospital’s former patients, some wearing bandages or warning that their replacement knee might set off ...

Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous ...

Of course, surgeons are devoted to the higher calling of healing the wounded. But in the US hospital system it’s the dollars ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...

New dietary guidelines from the British Dietetic Association say kiwis — along with rye bread and certain supplements — can ...

The guideline incorporates the latest advice on diagnosis and treatment, lowering proteinuria targets, and integrating new ...

Staphylococcus aureus infections remain a formidable health threat, responsible for the most infection-related deaths ...

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.